510(k) Report

510(k) · Decided

Decided

Intrastent LD (Large Diameter) Stent

K020528510(k) SpecialDecided Apr 16, 200256-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sulzer Intratherapeutics, Inc. · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Apr 16, 2002 as substantially equivalent to K991929 (Intratherapeutics, Inc., 1999) and 1 other predicate after a 56-day review. Its family tree reaches back 6 generations to 1991.

Decided
Apr 16, 2002
Review
56 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K911292 (1991). 19 ancestors in all, the oldest K885180 (1989). No later device cites it as a predicate yet.

  1. Root · 6 generations backK911292 Schneider Wallstent (R)Pfizer Hospital Products Group, Inc. · 1991
  2. 5 generations backK961262 Wallstent Transhepatic Biliary Endoprosthesis/Wallstent Endoscopic…Boston Scientific Scimed, Inc. · 1996
  3. 4 generations backK964119 Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc. · 1997 · Recalled
  4. 3 generations backK980653 Perflex Stainless Steel Stent and Delivery SystemCordis Corp. · 1998
  5. 2 generations backK991929 IntrastentIntratherapeutics, Inc. · 1999
  6. 1 generation backK993904 Intrastent Doublestrut LDIntratherapeutics, Inc. · 2000 · Recalled
  7. This deviceK020528 Intrastent LD (Large Diameter) StentSulzer Intratherapeutics, Inc. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K911292Schneider Wallstent (R)Pfizer Hospital Products Group, Inc.1991—
−5K961262Wallstent Transhepatic Biliary Endoprosthesis/Wallstent Endoscopic Biliary…Boston Scientific Scimed, Inc.1996—
−4K964119Wallstent Transhepatic Biliary EndoprosthesisBoston Scientific Scimed, Inc.19976
−3K980653Perflex Stainless Steel Stent and Delivery SystemCordis Corp.1998—
−2K991929IntrastentIntratherapeutics, Inc.1999—
−1K993904Intrastent Doublestrut LDIntratherapeutics, Inc.20001
0 (this device)K020528Intrastent LD (Large Diameter) StentSulzer Intratherapeutics, Inc.2002—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198930
199010
199130
199210
199410
199610
199720
199810
FIG. 1 — Lineage of K020528, 1991–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991929Intrastent
Summary page 1
…e expanded state upon balloon deflation. Summary of technological characteristics: The IntraStent Mega and Max LD stents provide a larger version the IntraStent™ Stent (K991929), allowing expanded diameters of 9-12mm and 12mm. The IntraStent devices are balloon expandable stents fabricated by cutting an e…
Intratherapeutics, Inc.1999—
*K993904Intrastent Doublestrut LD
Summary page 2
…edicate IntraStent™ Stent (K991929). The IntraStent is substantially equivalent* to the currently marketed IntraStent stent (K991929) and the IntraStent DoubleStrut LD (K993904) as a palliative treatment for malignant strictures of the biliary tree. As demonstrated, the modified IntraStent stent is identi…
Intratherapeutics, Inc.20001

Also cleared against K991929: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 5 companies; a new generation was cleared every 1.2 years on median.
  • 3 of the 19 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K991929.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The IntraStent® Mega™ LD (Large Diameter) Stent — Biliary Indication and the IntraStent® Max™ LD (Large Diameter) Stent — Biliary Indication are intended as a palliative treatment of malignant neoplasms in the biliary tree.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K020528: Intrastent LD (Large Diameter) Stent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K020528

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026